Specialty / Expertise

Breast cancer

Research Interests

Investigational breast cancer treatment, bone metastases

Current Research Projects

Trial of Adjuvant Bisphosphonates for Prevention of Bone Metastases in Early Stage Breast Cancer
Trial of Celecoxib for Breast Cancer Chemoprevention
Study Investigating Barrier to Accrual to Clinical Trials

Research Staff

Training

Dr. Gralow received her undergraduate degree from Stanford University, Palo Alto, CA and her MD from University of Southern California, Los Angeles, CA. She completed her Internal Medicine Residency at the Harvard Medical School's Brigham and Women's Hospital in Boston, MA. She was a Post-Doctoral Fellow in Oncology at the University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B, Winer EP. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol 2008 26(5):814-819.

Gralow JR, Zujewski JA, Winer E. Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions. J Clin Oncol 2008 26(5):696-697.

Gralow JR, Tripathy D. Managing Metastatic Bone Pain: The Role of Bisphosphonates. J Pain Symptom Management, 2007.

Gralow J. Bone Density in Breast Cancer: When to Intervene? J Clin Oncol 2007.

Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweethenham JW, Vahat LT, Winn RJ; American Society of Clinical Oncology. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology. J Clin Oncol 2007 25:146-162.

Gralow JR. Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer. Clin Breast Cancer 2005.

Gralow JR. Optimizing the treatment for metastatic breast cancer. Breast Cancer Res Treat 2005; 89 Suppl 1:S9-S15.

Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR. ASCO technology assessment on the use of aromatose inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status Report 2004. J Clin Oncol 2004.